Friday, October 9, 2026 SourcesAbout🌓
🇺🇸 US ▾
BREAKING
› Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials› Podcast: One country musician is calling for other artists to oppose assault rifles› Bidets save you money and reduce waste — we tested the best options out there› 50+ products to make your life easier and our planet cleaner› Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love› A head-to-toe guide of how men should dress this spring, and where they should shop› 42 of the most useful travel products you can buy on Amazon› The 7 best high-yield savings accounts of April 2023› Taxes are due tomorrow. Here's how to file for an extension› Composting is an easy way to reduce food waste. Here's how to do it› Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials› Podcast: One country musician is calling for other artists to oppose assault rifles› Bidets save you money and reduce waste — we tested the best options out there› 50+ products to make your life easier and our planet cleaner› Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love› A head-to-toe guide of how men should dress this spring, and where they should shop› 42 of the most useful travel products you can buy on Amazon› The 7 best high-yield savings accounts of April 2023› Taxes are due tomorrow. Here's how to file for an extension› Composting is an easy way to reduce food waste. Here's how to do it
Business

The timing of AI leaders' calls for a slowdown is too convenient to ignore

Business Insider ·
The timing of AI leaders' calls for a slowdown is too convenient to ignore

OpenAI CEO Sam Altman and Anthropic CEO Dario Amodei Getty Images Top AI leaders want to slow the development of their top-end models.

The coordinated response comes as AI faces lots of headwinds.

That doesn't mean their concerns aren't real, but the timing is also self-serving.

Imagine a pharmaceutical company spends nearly four years touting a ground-breaking new medicine that will cure all diseases.

Early evidence supporting those claims is limited, and massive questions remain, but the company continues to make progress.

Criticism and concerns, while addressed, don't slow its aggressive push.

After all, investors believe this is the real deal. (Or at least a really good bet.) And then right before the pharma company unveils its fancy new drug, it gives a shocking update: It turns out the medicine could also be a poison.

So, for the safety of all involved, progress in the space needs to be slowed to ensure things don't go off the rails.

That's basically the big debate going on in AI land these days.

After years of telling us how groundbreaking their tech will be, AI leaders like Anthropic's Dario Amodei , OpenAI's Sam Altman, and xAI's Elon Musk are saying we need to slow the development of their most advanced models or risk a very dark future for humanity.

Is it about safety, or self-preservation? A tumultuous 2026 for AI Silicon Valley has been warning about the downside of AI for years .

But this weekend was the type of coordinated response the industry has rarely seen.

The calls for an AI slowdown aren't happening in a vacuum.

The industry's facing pressure on multiple fronts these days.

Read the full article on Business Insider ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.businessinsider.com — the content belongs to Business Insider.

More from Business Insider

See all ›

More in Business

See all ›